Medtrum Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $29M

  • Investors
  • 8

Medtrum General Information


Developer of diabetes management devices. The company develops and markets devices and related software used to manage and monitor glucose levels and insulin pump status of diabetic patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Electronics (B2C)
Other Industries
Application Software
Corporate Office
  • Building 3, No. 200 Newton Road, Zhangjiang Hi-Tech Park
  • Shanghai
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medtrum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 24-Dec-2018 $29M 0000 Completed Generating Revenue
2. Later Stage VC 16-Nov-2014 Completed Generating Revenue
1. Early Stage VC 31-Mar-2010 Completed Generating Revenue
To view Medtrum’s complete valuation and funding history, request access »

Medtrum Patents

Medtrum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1010106-S1 Drug infusion device Active 27-Sep-2021 0
EP-4274633-A1 Skin patch drug infusion device Pending 05-Jan-2021 00000000000
EP-4274638-A1 Skin patch drug infusion device Pending 05-Jan-2021 00000000000
EP-4274635-A1 Drug infusion device with security base Pending 05-Jan-2021 0000000000
EP-4274646-A1 Drug infusion device with embedded power supply Pending 05-Jan-2021 A61M5/14248
To view Medtrum’s complete patent history, request access »

Medtrum Executive Team (2)

Name Title Board Seat Contact Info
Cuijun Yang Founder & Chief Executive Officer
Jie Lu Project Manager
To view Medtrum’s complete executive team members history, request access »

Medtrum Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3E Bioventures (China) Venture Capital Minority 000 0000 000000 0
BOCGI Zheshang Capital Growth/Expansion Minority 000 0000 000000 0
Morningside Group Venture Capital Minority 000 0000 000000 0
Shanghai Nuokai Investment Management Venture Capital Minority 000 0000 000000 0
HongShan Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »